Skip to main content
. Author manuscript; available in PMC: 2013 Sep 7.
Published in final edited form as: Oncogene. 2012 Apr 30;32(10):1305–1315. doi: 10.1038/onc.2012.140

Fig 2e. Expression/localization of cdc42 GEFs in Caco-2 and Caco-2 ShPTEN cells.

Fig 2e

Effects of PTEN expression and PI3K modulating treatment on expression and subcellular localization of “morphogenic” and non-morphogenic” cdc42 GEFs (n=3). E-cadherin and GAPDH were used as membrane and cytosolic markers respectively.